Uğur Şahin, BioNTech CEO (Bernd von Jutrczenka/dpa via AP Images)

Ex­clu­sive: BioN­Tech ac­quires lipid nanopar­ti­cle start­up found­ed by George Ma­son and UPenn sci­en­tists

BioN­Tech, the Ger­man drug com­pa­ny fa­mous for de­vel­op­ing a Covid-19 vac­cine with Pfiz­er, has ac­quired Aex­eR­NA and its nov­el lipid nanopar­ti­cles for mR­NA med­i­cines, …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA